Pharmacologic prophylaxis of supraventricular tachyarrhythmias after coronary artery bypass.
Coronary artery bypass surgery is an accepted treatment for patients with coronary artery disease. Perioperative morbidity includes development of supraventricular arrhythmias. To prevent this, prophylactic administration of drugs such as calcium channel blockers, digoxin, and beta-blockers have been advised.
Dorovenis
S A
SA
Department of Pharmacy Services, Toronto Hospital-Western Division, Ontario, Canada.
Weiner
B
B
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D001026:Coronary Artery Bypass / Q000009:adverse effects*; D003327:Coronary Disease / Q000601:surgery*; D004077:Digoxin / Q000627:therapeutic use; D006801:Humans; D011433:Propranolol / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D013617:Tachycardia, Supraventricular / Q000517:prevention & control*; D014700:Verapamil / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D000889:Anti-Arrhythmia Agents; D002121:Calcium Channel Blockers; D004077:Digoxin; D011433:Propranolol; D014700:Verapamil